N4-HydroxycytidineSARS-CoV-2

Priya Kumar1, Xiaoxiao Zhang2, Rahul Shaha3

  • 1Department of Molecular Oncology, Göttingen Center of Molecular Biosciences (GZMB), University Medical Center Göttingen, 37077, Göttingen, Germany.

Antiviral research
|September 18, 2024
PubMed
概括

科学家们在SARS-CoV-2尖端蛋白中发现了新的突变,这些突变有助于病毒抵抗单克隆抗体治疗. 这一发现有助于预测抗体对未来COVID-19变种的有效性.